T1 hyperintensity in the brain after multiple intravenous injections of gadolinium-based contrast agents

Acta Radiologica

Volumn 57, Issue 4, 2016, Pages 389-391

  Thomsen, Henrik S ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOLINIUM PENTETATE MEGLUMINE; SODIUM CHLORIDE; CONTRAST MEDIUM; GADOLINIUM;

BLOOD BRAIN BARRIER; BRAIN; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MANGANESE BLOOD LEVEL; NEPHROGENIC SYSTEMIC FIBROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; X RAY; ANIMAL; INTRAVENOUS DRUG ADMINISTRATION; PATHOLOGY; RAT;

ANIMALS; BRAIN; CONTRAST MEDIA; GADOLINIUM; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; RATS;

EID: 84964316480     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1177/0284185115626479     Document Type: Review

References (17)

1. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephro-genic systemic fibrosis? Nephrol Dial Transplant 2006;21: 1104-1108.
2. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:359-2362.
3. Thomsen HS. Nephrogenic systemic fibrosis and gadolinium-based contrast media. In: Thomsen HS, Webb JAW (eds) Contrast Media: Safety Issues and ESUR Guidelines, 3rd edn. Heidelberg: Springer, 2014, pp.201-217.
4. Chabanova E, Logager VB, Moller JM, et al. Manganese based MR contrast agents: Formulation and Clinical applications. Open Drug Safety J 2011;2:29-38.
5. Kanda T, Ishii K, Kawaguchi H, et al. High signal intensity in the dentate nucleus and globus pallidus on unen-hanced T1-weighted MR images: relationship with increasing dose of a gadolinium-based contrast material. Radiology 2014;270:834-841.
6. Kanda T, Osawa M, Oba H, et al. High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: Association with linear versus macrocyclic gadolinium chelate administration. Radiology 2015;275: 803-809.
7. Ramalho J, Castillo M, AlObaidy M, et al. High signal intensity in globus pallidus and dentate nucleus on unen-hanced T1-weighted MR images: Evaluation of two linear gadolinium-based contrast agents. Radiology 2015;276:836-844.
8. Radbruch A, Weberling LD, Kieslich PJ, et al. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 2015;275:783-791.
9. Adin ME, Kleinberg L, Zan VE, et al. Hyperintense dentate nuclei on T1-weighted MRI: relation to repeat gadolinium administration. Am J Neuroradiol 2015;36: 1859-1865.
10. Quattrocchi CC, Mallio CA, Errante Y, et al. Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced mangnetic resonance examinations with no systemic interval therapy. Invest Radiol 2015;50: 470-472.
11. Roberts DR, Holden KR. Progressive increase of T1 signal intensity in the dentate nucleus and globus pal-lidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast. Brain Dev 2015. doi: 10.1016/j.braindev. 2015.08.009.
12. Robert P, Lehericy S, Grand S, et al. T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of gadolinium-based contrast agents in healthy rats. Difference between linear and macrocyclic agents. Invest Radiol 2015;50:473-480.
13. Kanda T, Kukusato T, Matsuda M, et al. Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: Evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 2015;276: 228-232.
14. McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015;275: 772-782.
15. Kanal E, Tweedle MF. Residual or retained gadolinium: practical implications for radiologists and our patients. Radiology 2015;276:228-232.
16. Brunberg JA, Kanal E, Hirsch W, et al. Chronic acquired hepatic failure: MR imaging of the brain at 1.5T. Am J Neuroradiol 1991;12:909-914.
17. Oikonomou A, Chatzistefanou A, Zezoz P, et al. Basal ganglia hyperintensity on T1-weighted MRI in Rendu-Osler-Weber disease. J Magn Reson Imaging 2012;35: 426-430.